Farnoosh Saeedinejad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Farnoosh Saeedinejad has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Ali Tamayol
Department of Biomedical Engineering, University of Connecticut, Farmington, CT 06030, USA
1 shared publication - Armin Tahmasbi Rad
Department of Biomedical Engineering University of Connecticut Storrs CT 06269 USA
1 shared publication Arvind Manojkumar
Department of Health & Biomedical Sciences, University of Texas Rio Grande Valley, Brownsville, TX, USA
1 shared publication- Caroline R Garcia
Department of Health & Biomedical Sciences, University of Texas Rio Grande Valley, Brownsville, TX, USA
1 shared publication Deepa Roy
Department of Health & Biomedical Sciences, University of Texas Rio Grande Valley, Brownsville, TX, USA
1 shared publicationDelaram Ghanbariamin
Department of Biomedical Engineering, University of Connecticut Health Center, Farmington, CT 06030, USA
1 shared publication
Latest Publications
- 25 April 2025
- Published by Elsevier in Acta Biomaterialia
- Vol. 200, 358-377
In Situ-Formed Tissue-Adhesive Macroporous Scaffolds Enhance Cell Infiltration and Tissue Regeneration
- 25 April 2025
- Published by Elsevier in Acta Biomaterialia
- Vol. 200, 358-377
In Situ-Formed Tissue-Adhesive Macroporous Scaffolds Enhance Cell Infiltration and Tissue Regeneration
- Open Access
- 1 June 2022
- Published by Taylor & Francis in Nanomedicine
- Vol. 17 (13) , 959-978
Effect of Drug-To-Lipid Ratio on Nanodisc-Based Tenofovir Drug Delivery to The Brain for HIV-1 Infection
Background: Combination antiretroviral therapy has significantly advanced HIV-1 infection treatment. However, HIV-1 remains persistent in the brain; the inaccessibility of the blood–brain barrier a...
- 1 June 2022
- Published by Taylor & Francis in Nanomedicine
- Vol. 17 (13) , 959-978
Open AccessEffect of Drug-To-Lipid Ratio on Nanodisc-Based Tenofovir Drug Delivery to The Brain for HIV-1 Infection
Background: Combination antiretroviral therapy has significantly advanced HIV-1 infection treatment. However, HIV-1 remains persistent in the brain; the inaccessibility of the blood–brain barrier a...